- Context
- My doctoral research looked for new antibacterial compounds in marine actinomycetes from 22 sediment samples collected at 12 coastal sites, targeting four bacteria behind hospital-acquired lower respiratory tract infections.
- Challenge
- Very few of the 1,928 isolates showed activity, cultures grew slowly with almost no metabolite production, and recurring contamination kept slowing the work.
- My role
- First author. I collected samples, helped design the experiments, ran the investigation and analysis, validated the data, and co-wrote the paper as part of a nine-person team.
- Approach
- Traced recurring contamination to a shared incubator and addressed the cause.
- Reviewed the literature to choose better growth media, which gave stronger growth in less time.
- Tested pH, temperature, carbon and nitrogen sources and salt levels to find the best production conditions.
- Ran every assay in triplicate, verified results with one-way ANOVA in SPSS, and wrote SOPs and standardized test methods for each assay.
- Outcome
- Inhibition of the target pathogens roughly doubled after optimization. SZ33 was the only isolate active against all four pathogens and outperformed streptomycin against three of them. I submitted it to NCBI GenBank (OQ726229), and the work was published in a peer-reviewed, open-access journal.
- Transferable to
Transformation teams
- R&D process improvement
- Laboratory modernization
- Current-state analysis
Biopharma
- Root-cause investigation
- SOP and test method standardization
- Data verification
Sahar Zarrien, PhD
Microbiologist | GMP quality | Capability development
Microbiologist and quality-minded scientist with 12+ years of teaching, laboratory instruction, and research. I have led a team of 12 to 15 staff each year, mentored junior researchers, identified a novel bacterial strain now in NCBI GenBank, and published as first author. I'm GMP-trained through CATTI and BioTalent Canada, and building quality assurance and biotechnology skills through ongoing college coursework. I bring careful documentation, safe laboratory practice, and a habit of teaching others to do the work accurately.
Ontario, Canada. Permanent Resident, authorized to work in Canada.
Scientific depth
PhD in Microbiology. Field sampling, method optimization, structured troubleshooting and research documentation, ending in a peer-reviewed first-author paper.
Capability building
12+ years in science education, leading 12–15 instructional staff each year, designing courses and mentoring junior researchers.
Adoption that lasts
I break new methods and tools into small, practical steps people can try straight away, then stay close while they practise.
Transformation succeeds when people understand, trust and adopt new ways of working. I bring the scientific credibility to engage researchers and the learning expertise to help them change.
Same strengths, two settings
Where my research and education experience would contribute. My regulatory knowledge is awareness-level, built through Canadian GxP training rather than industry employment.
On a Life Sciences transformation team
Bringing a scientist's view to programs that change how R&D, laboratory and quality teams work.
- Current-state interviews and workflow mapping with scientific users, who I can talk to as a fellow scientist.
- Training, adoption and change workstreams for new laboratory and quality systems.
- Clear process documentation, SOPs and user guidance.
- Translating between scientists and technology or business teams.
Inside a biopharma or life sciences company
Supporting the quality, laboratory and training work that keeps regulated science running.
- GMP-aware SOPs, work instructions and technical reports.
- QA/QC support, drawing on root-cause investigation from research and formal training in deviation and CAPA principles.
- Scientific training and onboarding, plus checking that procedures are actually followed.
- Adoption support when new instruments, systems or procedures roll out.
What I bring to either setting
Select any capability to see the evidence behind it.
Understanding how research work actually gets done: workflows, bottlenecks, and what scientists need from new tools.
How I bring this. Ran a multi-year doctoral program from field sampling at 12 coastal sites through optimization, extraction, analysis and publication, managed reagent and consumable inventory throughout, and kept equipment logbooks, including calibration and maintenance records, for autoclaves, incubators and laminar airflow cabinets, with basic troubleshooting and preventive maintenance.
SOPs, work instructions and reports written with GMP and GLP expectations in mind, and with data integrity protected.
How I bring this. Drafted SOPs and standardized test methods for each assay, and peer-reviewed lab records for completeness and traceability. As department head, I audited the lab SOPs and lesson plans teachers worked from.
Training designed around what people need to do differently, not only what they need to know.
How I bring this. Designed Biology and Chemistry courses and ICSE-level practice materials, and taught 1,200+ students across India and Canada.
Helping people take up new ways of working through small, practical steps they can try straight away.
How I bring this. Introduced updated teaching methods to 12–15 instructional staff each year and supported them through the change.
Turning complex science into guidance people can act on.
How I bring this. First-author open-access paper (2025) with 7,000+ views and 5,200+ downloads, 1st place in oral presentation at Biomind 2025, and Best Poster at IMABM 2021.
Using AI to work faster on documents and learning materials, with human review built in.
How I bring this. I use Claude, ChatGPT and Gemini to draft question papers, MCQs and flowcharts, then check every item for accuracy before anything is used.
From 1,928 isolates to one broad-spectrum strain
My PhD asked whether bacteria from underexplored marine sediments could yield new antibacterials against hospital-acquired lower respiratory tract infections, where antibiotic resistance keeps rising. One strain, Streptomyces rochei SZ33, stood out: it was the only isolate active against all four target pathogens.
Question
Can bacteria from underexplored marine sediments yield new antibacterials against hospital-acquired respiratory infections, where resistance keeps rising?
Method
22 sediment samples from 12 coastal sites in Tamil Nadu. Isolation, agar overlay screening, growth and production optimization, GC-MS, FTIR and 16S rRNA sequencing. The study's in silico work (molecular docking) was part of the nine-person team's analysis.
Findings
SZ33 inhibited all four pathogens, including Klebsiella pneumoniae. Optimization roughly doubled inhibition, and its extract produced larger inhibition zones than streptomycin against three of the four.
Impact
A new strain on NCBI GenBank and a set of candidate compounds. The work is in vitro and in silico, so in vivo, safety and pharmacokinetic studies come next.
Figures from the published paper. Bar lengths use a log scale so every stage stays readable.
- PhD, MicrobiologyDayananda Sagar University, India, 2025
- Earlier degreesMSc, Microbiology, Bangalore University, 2009; BSc, Botany, Zoology and Chemistry, University of Calcutta, 2007
- Recognition1st place in oral presentation, Biomind 2025, and Best Poster, IMABM 2021
First-author publication, peer-reviewed and open access
Streptomyces rochei SZ33, a Novel Antibacterial Reservoir against Nosocomial Lower Respiratory Tract Infections: A Comprehensive In Vitro and In Silico Study
Journal of Pure and Applied Microbiology, 2025, 19(3): 2120–2140. Indexed in Scopus.
Received 12 May 2025, accepted 24 June 2025, published 3 September 2025.
Journal site figures, October 2026.
- Marine sediment sampling
- Actinomycete isolation
- Agar overlay and well diffusion assays
- Growth and production optimization
- Solvent extraction
- TLC
- Column chromatography
- GC-MS data interpretation
- FTIR data interpretation
- 16S rRNA sequencing
- BLAST
- MEGA11 phylogenetics
- SPSS: ANOVA and Tukey
Transferable skill stories
Real work from research and education, mapped to transformation and biopharma work. These are not consulting case studies.
AI and digital fluency
I use AI for documents and learning materials, never for research. What I'm most careful about is checking its output.
How I use AI responsibly
Verify every claim
Every AI-drafted fact is checked against the source before I use it.
Ask for uncertainty, not invention
I tell the AI to flag what it doesn't know. I've still caught invented figures, titles and links, which is why the check matters.
AI
- Claude
- ChatGPT
- Gemini
Productivity and collaboration
- Word
- Excel
- PowerPoint
- Teams
- OneNote
- SharePoint
- OneDrive
- Google Docs and Sheets
- Zoom
- Google Meet
Scientific and data
- SPSS
- BLAST
- MEGA11
- Excel
- Python (basic)
Coursework and foundational exposure
- ELISA
- SDS-PAGE
- Bacterial endotoxin (LAL) testing
- UV-Vis
- HPLC
- Empower
How I'd help a team adopt AI
Start small with tasks people do every week, practise hands-on rather than in one-off sessions, and build human review into the workflow from day one.
How I think about adoption
People adopt change faster when they can practise straight away, rather than just being told about it.
Technology only transforms how an organization works if people actually know how to use it well.
Organizations need genuine human review of AI output, not just a policy on paper.
Latest insights
See all insightsGxP training and Canadian readiness
Five BioTalent Canada badges, issued 4 September 2026. Each one links to its public record on Credly.
Good Manufacturing Practice (GMP) Fundamentals
SOPs, quality control requirements, investigations, health and safety.
Verify on CredlyGood Laboratory Practices (GLP) Fundamentals
Laboratory notebooks, equipment and materials, SOPs.
Verify on CredlyGood Clinical Practice (GCP) Fundamentals
Clinical research principles, essential documents, SOPs.
Verify on CredlyQA/QC Fundamentals
SOPs, quality management systems, health and safety.
Verify on CredlyScientific Report Writing Fundamentals
Reports aligned with GLP, GCP, GMP and QA/QC standards.
Verify on Credly
Advanced Therapies GMP Onboarding and Introduction to ATMPs
BioSafe 1BS0 Biological Safety
Polymerase Chain Reaction (PCR), gel electrophoresis and ImageJ
Applied AI Fundamentals for Biomanufacturing
In progress, expected Dec 2026Biotechnology Unit Operations, Chemical Instrumentation and Analysis, Quality Assurance Systems
In progress, expected Dec 2026WHMIS 2015 for Workers
Ontario College of Teachers: Intermediate Science and Senior Biology
Permanent Resident, authorized to work in Canada
Introduction to the LIMS and Other Information Systems (General Certificate)
HPLC fundamentals and basic Python
MSc, Microbiology
MA, Education, and BEd, Chemistry and Biology
What I'm working on now
Last updated November 2026
- In progress
Mohawk College coursework
Part-time credit courses: Biotechnology Unit Operations, Chemical Instrumentation and Analysis, and Quality Assurance Systems, including practical HPLC work. Expected December 2026.
- In progress
Applied AI Fundamentals for Biomanufacturing
A live, instructor-led online micro-credential from Keyin College through BioTalent Canada's BioReady Ontario: responsible AI use, checking AI output, and AI-assisted workflows, ending in a capstone project. About 40 hours, November to December 2026.
- Completed
Five BioTalent Canada GxP badges
GMP, GLP, GCP, QA/QC and Scientific Report Writing, earned September 2026.
- Open
Conversations about roles
Life Sciences transformation and biopharma quality, laboratory or training roles across Canada.
Let's talk
I want to help scientific teams adopt new ways of working, whether on a Life Sciences transformation team or inside a biopharma organization's quality, laboratory or training function. Based in Ontario and open to roles across Canada.
All fields are required unless marked optional.
Sent securely. Your details are only used to reply to you.